What's new? Log in Free sign up

abrdn Gold ETF Trust (SGOL)

Company Profile

Company profile

Ticker

SGOL

Website

www.aberdeenstandardetfs.us

Incorporated

Location

Fiscal year end

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co. • Mississippi Power • Alabama Power • Teva Pharmaceutical Industries Limited • Abbott Laboratories • Eli Lilly and • Bristol-Myers Squibb • Viatris ...

Former names

Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

SGOL stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

Quarterly report

12 Nov 24

Termination of a Material Definitive Agreement

Prospectus supplement

Quarterly report

9 Aug 24

Entry into a Material Definitive Agreement

Prospectus supplement

Quarterly report

9 May 24

Prospectus supplement

29 Feb 24

Quarterly report

8 Nov 23

Latest ownership filings

ETFS Gold Trust

ETFS Gold Trust

ETFS Gold Trust

ETFS Gold Trust

ETFS Gold Trust

ETFS Gold Trust

Financial summary

Financial statements Chart SGOL financial data

Quarter (USD)	Sep 24	Jun 24	Mar 24	Dec 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Institutional ownership, Q3 2024

SGOL institutional ownership history Ownership history

0.0% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	1	2	-50.0%
Opened positions	0	0
Closed positions	1	0	NEW
Increased positions	0	0
Reduced positions	0	1	EXIT

13F shares	Current	Prev Q	Change
Total value	25.00 k	1.28 bn	-100.0%
Total shares	1.00 k	58.78 k	-98.3%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
AlphaMark Advisors	1.00 k	$25.00 k	0.0%

Largest transactions	Shares	Bought/sold	Change
NBT Bank N A	0.00	-57.78 k	EXIT
AlphaMark Advisors	1.00 k	0.00	0.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

News

From Benzinga Pro

Goldman Sachs Delays $3,000 Gold Forecast, Sees Fewer Rate Cuts In 2025

Goldman Sachs postpones gold price prediction to mid-2026, citing Fed decisions. Gold expected to reach $2,910/oz by end of 2025. Antimony mining project in Idaho could boost US demand and reduce vulnerability to China's market control.

Gold Price Surge Pushes Rolex to Raise Prices for Iconic Watches

Amid gold's record-breaking 27% surge in 2024, Rolex SA increased prices on select luxury models, with precious metal timepieces rising by up to 8%. The yellow gold GMT-Master II now costs €44,600.

Gold Prices To Climb 7% In 2025 Amid Trump's Return To White House And Geopolitical Tensions: 'Momentum Is Taking Back Over'

Geopolitical tensions in the Middle East and Ukraine are also contributing to the bullish outlook for gold.

Gold Poised For Its Best Year In A Decade While Bitcoin Surges: Analysts Eye 2025 As A Golden Era For Precious Metal Amid Michael Saylor's Push For BTC As A Reserve Asset

'Go For Gold,' Says Goldman Sachs: Precious Yellow Metal Price Would Rise In 2025 Amid Central Bank Buying, Fed Rate Cuts

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.